Skip to content

Clinical trials

Fibrosis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: Taiwan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20041
20051
20071
20101
20151
20172
20181
20191
20211
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Unknown status4
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kaohsiung Medical University Chung-Ho Memorial Hospital3
89bio, Inc.2
National Taiwan University Hospital2
Novo Nordisk A/S2
Taipei Veterans General Hospital, Taiwan2
AbbVie1
Bristol-Myers Squibb1
Celgene1
China Medical University Hospital1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis21
Hepatitis C3
Liver Cirrhosis3
Acute Kidney Injury2
Digestive System Diseases2
Esophageal and Gastric Varices2
Fatty Liver2
Heart Failure2
Hepatitis B2
Hepatitis B, Chronic2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.